A Case of Ramipril-Induced Angioedema and Solar Purpura.

IF 1.7 4区医学 Q3 DERMATOLOGY

Advances in Skin & Wound Care Pub Date : 2024-11-01 DOI:10.1097/ASW.0000000000000236

Rabia Oztas Kara, Bahar Sevimli Dikicier, Bilge Elcin

引用次数: 0

Abstract

Abstract: This case report describes a patient who developed solar purpura after treatment for angioedema associated with ramipril, an angiotensin-converting enzyme inhibitor. The patient presented to the ED with angioedema. She had been using ramipril for 2 years. Two days after she was admitted, a malar "butterfly" rash occurred on her face and purpura on her lower lip and chin, as well as the extensor part of her forearm. After testing and review of the patient history, she was diagnosed with solar purpura and began topical corticosteroid and antiscar cream treatment. The patient's lesions healed with an atrophic scar in 3 weeks. To the authors' knowledge, this is the first such case to be reported in the literature.

查看原文本刊更多论文

雷米普利致血管性水肿合并太阳性紫癜1例。

摘要：本病例报告描述了一例患者在使用血管紧张素转换酶抑制剂雷米普利治疗血管性水肿后发生太阳紫癜。患者以血管性水肿就诊。她已经使用雷米普利2年了。入院两天后，她的脸上出现了颧骨“蝴蝶”疹，下唇和下巴以及前臂伸肌部位出现了紫癜。在检查和回顾病史后，她被诊断为日光性紫癜，并开始局部使用皮质类固醇和抗疤痕霜治疗。患者病变在3周内愈合并形成萎缩性瘢痕。据作者所知，这是文献中报道的第一例此类病例。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Advances in Skin & Wound Care DERMATOLOGY-NURSING

CiteScore

2.50

自引率

12.50%

发文量

271

审稿时长

>12 weeks

期刊介绍： A peer-reviewed, multidisciplinary journal, Advances in Skin & Wound Care is highly regarded for its unique balance of cutting-edge original research and practical clinical management articles on wounds and other problems of skin integrity. Each issue features CME/CE for physicians and nurses, the first journal in the field to regularly offer continuing education for both disciplines.